Company
Headquarters: Paris, France
CEO: Ms. Sophie Boissard
€1.45 Billion
EUR as of Jan. 1, 2026
US$1.71 Billion
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Korian provides integrated health and care services for the elderly in France, Germany, Belgium, Italy, Spain, and the Netherlands. The company operates long-term care nursing homes, specialized clinics, and assisted living and shared housing facilities for seniors, as well as offers homecare and hospital-at-home services. As of December 31, 2020, it operated 1,000 facilities with 88,651 beds. Korian has a partnership with Aedifica to invests in new property development projects in the Netherlands. The company was formerly known as Korian-Medica S.A. and changed its name to Korian in July 2015. Korian was founded in 2001 and is headquartered in Paris, France.
| Last Financial Reports Date | June 30, 2025 |
| Revenue TTM | €5.31 B |
| EBITDA | €1.06 B |
| Gross Profit TTM | €1.67 B |
| Profit Margin | -1.16% |
| Operating Margin | 3.80% |
| Quarterly Revenue Growth | 1.10% |
Korian has the following listings and related stock indices.
Stock: FSX: KO2 wb_incandescent
Stock: Euronext: KORI wb_incandescent